Cargando…

Janus Kinase Inhibitors and Coronavirus Disease (COVID)-19: Rationale, Clinical Evidence and Safety Issues

We are witnessing a paradigm shift in drug development and clinical practice to fight the novel coronavirus disease (COVID-19), and a number of clinical trials have been or are being testing various pharmacological approaches to counteract viral load and its complications such as cytokine storm. How...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gatti, Milo, Turrini, Eleonora, Raschi, Emanuel, Sestili, Piero, Fimognari, Carmela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401109/ https://www.ncbi.nlm.nih.gov/pubmed/34451835 http://dx.doi.org/10.3390/ph14080738

Ejemplares similares

Overview of the Anticancer Potential of the “King of Spices” Piper nigrum and Its Main Constituent Piperine
por: Turrini, Eleonora, et al.
Publicado: (2020)

The rationale for Janus kinase inhibitors for the treatment of spondyloarthritis
por: Veale, Douglas J, et al.
Publicado: (2019)

Marine Anthraquinones: Pharmacological and Toxicological Issues
por: Greco, Giulia, et al.
Publicado: (2021)

Sulforaphane Potentiates RNA Damage Induced by Different Xenobiotics
por: Fimognari, Carmela, et al.
Publicado: (2012)

Correction: Sulforaphane Potentiates RNA Damage Induced by Different Xenobiotics
por: Fimognari, Carmela, et al.
Publicado: (2012)

Cytotoxic and Antitumor Activity of Sulforaphane: The Role of Reactive Oxygen Species
por: Sestili, Piero, et al.
Publicado: (2015)

Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness?
por: Sestili, Piero, et al.
Publicado: (2020)

Discovery of Sulforaphane as an Inducer of Ferroptosis in U-937 Leukemia Cells: Expanding Its Anticancer Potential
por: Greco, Giulia, et al.
Publicado: (2021)

Ellagitannins in Cancer Chemoprevention and Therapy
por: Ismail, Tariq, et al.
Publicado: (2016)

Serious adverse events with novel beta-lactam/beta-lactamase inhibitor combinations: a large-scale pharmacovigilance analysis
por: Gatti, Milo, et al.
Publicado: (2021)

Antileukemic Activity of Sulforaphane in Primary Blasts from Patients Affected by Myelo- and Lympho-Proliferative Disorders and in Hypoxic Conditions
por: Fimognari, Carmela, et al.
Publicado: (2014)

Potential Effects of Pomegranate Polyphenols in Cancer Prevention and Therapy
por: Turrini, Eleonora, et al.
Publicado: (2015)

Effect of the Marine Polyketide Plocabulin on Tumor Progression
por: Turrini, Eleonora, et al.
Publicado: (2022)

Ten Years of Research on Fucoidan and Cancer: Focus on Its Antiangiogenic and Antimetastatic Effects
por: Turrini, Eleonora, et al.
Publicado: (2023)

Safety of Janus Kinase Inhibitors in Inflammatory Bowel Diseases
por: Núñez, Paulina, et al.
Publicado: (2023)

Deuterium Incorporation Protects Cells from Oxidative Damage
por: Sestili, Piero, et al.
Publicado: (2019)

The Combination of Physical Exercise with Muscle-Directed Antioxidants to Counteract Sarcopenia: A Biomedical Rationale for Pleiotropic Treatment with Creatine and Coenzyme Q10
por: Guescini, Michele, et al.
Publicado: (2017)

Evidence and Current Use of Levosimendan in the Treatment of Heart Failure: Filling the Gap
por: Conti, Nicolina, et al.
Publicado: (2021)

Relationship between adverse drug reactions to antibacterial agents and the Klebsiella pneumoniae carbapenemase-producing (KPC) Klebsiella pneumoniae outbreak: insight from a pharmacovigilance study
por: Gatti, Milo, et al.
Publicado: (2019)

Serotonin syndrome by drug interactions with linezolid: clues from pharmacovigilance-pharmacokinetic/pharmacodynamic analysis
por: Gatti, Milo, et al.
Publicado: (2020)

Itch and Janus Kinase Inhibitors
por: HAN, Yujin, et al.
Publicado: (2023)

Sulforaphane Potentiates Anticancer Effects of Doxorubicin and Cisplatin and Mitigates Their Toxic Effects
por: Calcabrini, Cinzia, et al.
Publicado: (2020)

Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase
por: Gatti, Milo, et al.
Publicado: (2021)

Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance
por: Raschi, Emanuel, et al.
Publicado: (2020)

Janus kinase inhibitors: jackpot or potluck?
por: Pavithran, Keechilat, et al.
Publicado: (2012)

Janus Kinase Inhibitors and Cell Therapy
por: Assal, Amer, et al.
Publicado: (2021)

Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis
por: Gatti, Milo, et al.
Publicado: (2020)

Marine Sponge Natural Products with Anticancer Potential: An Updated Review
por: Calcabrini, Cinzia, et al.
Publicado: (2017)

Overview of the Anticancer Profile of Avenanthramides from Oat
por: Turrini, Eleonora, et al.
Publicado: (2019)

Withania somnifera Induces Cytotoxic and Cytostatic Effects on Human T Leukemia Cells
por: Turrini, Eleonora, et al.
Publicado: (2016)

Safety of Janus Kinase Inhibitors in Older Patients: A Focus on the Thromboembolic Risk
por: Rajasimhan, Suraj, et al.
Publicado: (2020)

Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
por: Papierzewska, Małgorzata, et al.
Publicado: (2023)

JAK out of the Box; The Rationale behind Janus Kinase Inhibitors in the COVID-19 setting, and their potential in obese and diabetic populations
por: Menshawey, Rahma, et al.
Publicado: (2020)

Acneiform Lesions but not Acne after Treatment with Janus Kinase Inhibitors: Diagnosis and Management of Janus Kinase-acne
por: BALLANGER, Fabienne, et al.
Publicado: (2023)

Introduction to the Toxins Special Issue on Dietary and Non-Dietary Phytochemicals and Cancer
por: Fimognari, Carmela
Publicado: (2016)

Clinical significance of Janus Kinase inhibitor selectivity
por: Choy, Ernest H
Publicado: (2019)

Clinical significance of Janus Kinase inhibitor selectivity
por: Choy, Ernest H
Publicado: (2019)

Janus kinase inhibitors for the therapy of atopic dermatitis
por: Traidl, Stephan, et al.
Publicado: (2021)

Role of Janus Kinase Inhibitors in Therapy of Psoriasis
por: Słuczanowska-Głąbowska, Sylwia, et al.
Publicado: (2021)

Janus kinase inhibitors in autoimmune bullous diseases
por: Huang, Dawei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_evh5r2duisu78kub88e06i9hlq